AVI BioPharma will present data highlighting improved analogues of AVI’s phosphorodiamidate morpholino oligomer (PMO) chemistry. The data will be presented by Hong Moulton, director of Discovery Research. At
Medgenics has announced that one of the patients treated with the EPODURE tissue Biopumps continues to be effectively treated for anemia without a single erythropoietin (EPO) injection. The
The Government of Canada has taken initiatives to support healthcare professionals in treating and preventing H1N1 flu virus infections in Canada. The government has taken two initiatives. Accordingly,
Kamada has entered into an agreement with a US specialty pharmaceutical distributor company for the distribution of its product, intravenous alpha-1 antitrypsin (AAT-IV) in the US. Under the
EcoActive Surfaces has released OxiTitan VLR, a light powered antimicrobial coating effective against viruses and bacteria indoors. OxiTitan VLR is designed to be used as an adjunct to
Abbott has entered into an agreement with Pfizer to develop a molecular diagnostic test intended to screen non-small cell lung cancer (NSCLC) tumors, for the presence of gene
Gen-Probe has initiated a clinical trial intended to secure US regulatory approval of its PROGENSA PCA3 assay, a new molecular test that may help to determine the need
CEL -SCI is expanding the scope of its work for creating a new treatment and vaccination against the current H1N1 virus, and a future mutated form in which
A comparative effectiveness study performed by HealthCore published by Mayo Clinic has showed that asthma patients in general had better clinical outcomes with oral controllers than inhaled corticosteroids.
Cobra Biomanufacturing (Cobra) has signed an agreement with a European biotechnology company to provide development services for an Adenovirus-based product. The contract will focus on the application of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.